Epigenetic reprogramming with antisense oligonucleotides enhances the effectiveness of androgen receptor inhibition in castration-resistant prostate cancer

Xiao L.; Tien J.C.; Vo J.; Tan M.; Parolia A.; Zhang Y.; Wang L.; Qiao Y.; Shukla S.; Wang X.; Zheng H.; Su F.; Jing X.; Luo E.; Delekta A.; Juckette K.M.; Xu A.; Cao X.; Alva A.S.; Kim Y.; MacLeod A.R.; Chinnaiyan A.M.